- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Positive data from Phase 2 SCOPE trial with SCIB1
- Result of Annual General Meeting
- Holding(s) in Company
- Scancell Appoints Dr Phil L’Huillier as CEO
- Notice of AGM
- Results Year Ended 30 April 2024
- Notice of Final Results
- Strategic Partnership with PharmaJet
- Scancell to attend upcoming conferences
- Scancell Appoints Dr Nermeen Varawalla as CMO
More ▼
Key statistics
As of last trade, Scancell Holdings PLC (SCLP:LSE) traded at 14.00, 62.79% above the 52 week low of 8.60 set on May 03, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.50 |
---|---|
High | 14.50 |
Low | 14.00 |
Bid | 14.00 |
Offer | 14.50 |
Previous close | 14.50 |
Average volume | 1.34m |
---|---|
Shares outstanding | 929.60m |
Free float | 852.71m |
P/E (TTM) | -- |
Market cap | 134.79m GBP |
EPS (TTM) | -0.0068 GBP |
Data delayed at least 20 minutes, as of Nov 22 2024 14:27 GMT.
More ▼